Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases
Read more
Should it be approved, the tie-up will strengthen the tech giant’s position in a high-growth industry and will also give it the tools to penetrate the healthcare market
Read more
Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco
Read more
Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco
Read more
The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist.
Read more
The iPhone giant’s portfolio is at the heart of the defence it plays when the subject of an assertion – and analysis shows that much of it has been acquired rather than grown organically
Read more
Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco
Read more
In a rare public appearance, the Chinese telecom’s founder and CEO, Ren Zhengfei, reaffirms commitment to respect third-party patents and explains why paying more than the competition will keep his company ahead
Read more
The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist.
Read more
Three individuals have been selected for the honour by the IP Hall of Fame Academy: Hedy Lamarr, Judge Kathleen O’Malley and Professor Jeffrey Samuels
Read more
Patent focus has shifted to energy storage as cost-effectiveness achieved for wind and solar power, but the failure to address the role of IP hinders transfer mechanisms
Read more
Our annual benchmarking surveys – one for IP owners and one for private practice lawyers and attorneys – open today, focusing on issues such as licensing, valuation, patent office performance and the best litigation venues
Read more
Centrient’s head of IP lifts the lid on why the company has been putting more focus on IP enforcement in India and explains the attractions of trade secrets
Read more
New initiative may help the Broad and MilliporeSigma strike more licensing deals, but is unlikely to heal the deeper fractures in the CRISPR landscape
Read more
In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’
Read more
Centrient’s head of IP lifts the lid on why the company has been putting more focus on IP enforcement in India and explains the attractions of trade secrets
Read more
New initiative may help the Broad and MilliporeSigma strike more licensing deals, but is unlikely to heal the deeper fractures in the CRISPR landscape
Read more
In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’
Read more
Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco
Read more
There is not much time left to make nominations for the 2019 edition of IAM Strategy 300, our exclusive guide on the world's best IP strategists.
Read more
The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist.
Read more
New initiative may help the Broad and MilliporeSigma strike more licensing deals, but is unlikely to heal the deeper fractures in the CRISPR landscape
Read more
In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’
Read more
A*STAR’s head of IP and corporate services Suresh Sachi sets out his approach to partnering with biopharma innovators, the exclusivity-related stumbling blocks – and how to overcome them
Read more
Patent focus has shifted to energy storage as cost-effectiveness achieved for wind and solar power, but the failure to address the role of IP hinders transfer mechanisms
Read more
The tech giant saw a steep drop in the number of US patents granted in 2018 after having spent years building its portfolio organically and through strategic acquisitions
Read more
After a WIPO report in April, new analysis from the UK IP Office sheds further light on this rapidly growing area and confirms that, despite a Chinese filing surge, the US continues to dominate
Read more
The world’s largest life sciences company demonstrates that it is still a major presence in the M&A landscape, despite its stated focus on organic growth.
Read more
New initiative may help the Broad and MilliporeSigma strike more licensing deals, but is unlikely to heal the deeper fractures in the CRISPR landscape
Read more
In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’
Read more
A*STAR’s head of IP and corporate services Suresh Sachi sets out his approach to partnering with biopharma innovators, the exclusivity-related stumbling blocks – and how to overcome them
Read more
A pioneer in Asia, a renowned US judge and the head of IP at one of the world’s most innovative companies are this year’s inductees into the IP Hall of Fame. Ella Cheong, Richard Linn and Kevin Rhodes were selected to join the pantheon by the IP… Read more
Centrient’s head of IP lifts the lid on why the company has been putting more focus on IP enforcement in India and explains the attractions of trade secrets
Read more
A*STAR’s head of IP and corporate services Suresh Sachi sets out his approach to partnering with biopharma innovators, the exclusivity-related stumbling blocks – and how to overcome them
Read more
Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco
Read more
The tech giant saw a steep drop in the number of US patents granted in 2018 after having spent years building its portfolio organically and through strategic acquisitions
Read more
In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’
Read more
The iPhone giant’s portfolio is at the heart of the defence it plays when the subject of an assertion – and analysis shows that much of it has been acquired rather than grown organically
Read more
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.
